Advertisement

Journal of Bone and Mineral Metabolism

, Volume 36, Issue 1, pp 103–110 | Cite as

Prevalence of vertebral fracture and densitometric osteoporosis in Spanish adult men: The Camargo Cohort Study

  • José M. Olmos
  • José L. Hernández
  • Josefina Martínez
  • Emilio Pariente
  • Jesús Castillo
  • Daniel Prieto-Alhambra
  • Jesús González-Macías
Original Article

Abstract

The aim of this study was to assess the prevalence of densitometric osteoporosis and vertebral fractures in Spanish men aged ≥50 years, and to study how the relationship between them may change depending on how osteoporosis is diagnosed. A community-based population of 1003 men aged ≥50 years was studied. Bone mineral density (BMD) was measured by DXA at the lumbar spine, femoral neck and total hip. Vertebral fractures were assessed by lateral thoracic and lumbar spine radiographs. The prevalence of osteoporosis was estimated with both the World Health Organization (WHO) (T-score of <−2.5 at the femoral neck, calculated using the young white female normal reference database) and the National Osteoporosis Foundation (NOF) criteria (T-score of <−2.5 at the femoral neck, total hip or lumbar spine, calculated using the young white male normal reference database). The prevalence of osteoporosis using the WHO criterion was 1.1% and using the NOF criterion was 13%, while that of vertebral fractures was 21.3%. The area under the curve (AUC) for the relationship between BMD and vertebral fracture prevalence was 0.64. The odds ratio for osteoporosis using the WHO definition was 2.57 (p = 0.13), and 1.78 (p = 0.007) using the NOF definition. Vertebral fracture prevalence rose with age. The prevalence of osteoporosis increased only moderately in men aged >70 years with the WHO criterion, and showed no change using the NOF definition. The prevalence of osteoporosis in Spanish men using the WHO definition is too small to have any meaningful clinical use. Although the figure is higher using the NOF definition, it would seem that population-based studies of BMD in men are of questionable value.

Keywords

Vertebral fracture Osteoporosis Bone mineral density Men 

Notes

Acknowledgements

Funded by grants from the Instituto de Salud Carlos III (PI15/00521), and the National Network for Aging Studies (RETICEF, Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad) (RD12/0043/0009), that included FEDER funds from the EU, Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Spain.

Compliance with ethical standards

Conflict of interest

All authors declare that they have no conflict of interest.

Supplementary material

774_2017_812_MOESM1_ESM.docx (24 kb)
Supplementary material 1 (DOCX 23 kb)

References

  1. 1.
    Ebeling PR (2008) Clinical practice. Osteoporosis in men. N Engl J Med 358:1474–1482CrossRefPubMedGoogle Scholar
  2. 2.
    Fransen M, Woodward M, Norton R, Robinson E, Butler M, Campbell AJ (2002) Excess mortality or institutionalisation after hip fracture: men greater risk than women. J Am Geriatr Soc 50:685–690CrossRefPubMedGoogle Scholar
  3. 3.
    Nguyen ND, Pongchaikayul C, Center JR, Eisman JA, Nguyen TV (2005) Identification of high-risk individuals for hip fracture: A 14-year prospective study. J Bone Miner Res 20:1921–1928CrossRefPubMedGoogle Scholar
  4. 4.
    Henry MJ, Pasco JA, Korn S, Gibson JE, Kotowicz MA, Nicholson GC (2010) Bone mineral density reference ranges for Australian men: Geelong Osteoporosis Study. Osteoporos Int 21:909–917CrossRefPubMedGoogle Scholar
  5. 5.
    Looker AC, Johnston CC, Lindsay RL, Wahner HW, Dunn WL, Calvo MS, Heyse SP, Lindsay RL (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768CrossRefPubMedGoogle Scholar
  6. 6.
    Looker AC, Melton JL III, Harris TB, Borrud LG, Shepherd JA (2010) Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III. J Bone Miner Res 25:64–71CrossRefPubMedGoogle Scholar
  7. 7.
    Tenenhouse A, Joseph L, Kreiger N, Poliquin S, Murray TM, Blondeau L, Berger C, Hanley DA, Prior JC; CaMos Research Group. Canadian Multicentre Osteoporosis Study (2000) Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 11:897–904CrossRefGoogle Scholar
  8. 8.
    Szulc P, Marchand F, Duboeuf F, Delmas PD (2000) Crosssectional assessment of age-related bone loss in men: the MINOS study. Bone 26:123–129CrossRefPubMedGoogle Scholar
  9. 9.
    Diaz Curiel M, Carrasco de la Pena J, Honorato Perez J, Perez Cano R, Rapado A, Ruiz Martinez I (1997) Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Osteoporosis Int 7:59–64CrossRefGoogle Scholar
  10. 10.
    Larijani B, Moayyeri A, Keshtkar AA, Hossein-Nezhad A, Soltani A, Bahrami A, Omrani GH, Rajabian R, Nabipour I (2006) Peak bone mass of Iranian population: the Iranian Multicenter Osteoporosis Study. J Clin Densitom 9:367–374CrossRefPubMedGoogle Scholar
  11. 11.
    Sawka AM, Papaioannou A, Josse RG, Murray TM, Ioannidis G, Hanley DA, Prior JC, Thabane L, Papadimitropoulos EA, Gafni A, Pickard L, Anastassiades T, Kirkland S, Adachi JD; CaMos Research Group (2006) What is the number of older Canadians needed to screen by measurement of bone density to detect an undiagnosed case of osteoporosis? a population-based study from CaMos. J Clin Densitom 9:413–418CrossRefGoogle Scholar
  12. 12.
    Jacobs JW, Da Silva JA, Armbrecht G, Bijlsma JW, Verstappen SM (2010) Prediction of vertebral fractures is specific for gender and site of bone mineral density measurement. J Rheumatol 37:149–154CrossRefPubMedGoogle Scholar
  13. 13.
    Cass AR, Shepherd AJ (2013) Validation of the Male Osteoporosis Risk Estimation Score (MORES) in a primary care setting. J Am Board Fam Med 26:436–444CrossRefPubMedGoogle Scholar
  14. 14.
    Ensrud KE, Taylor BC, Peters KW, Gourlay ML, Donaldson MG, Leslie WD, Blackwell TL, Fink HA, Orwoll ES, Schousboe J, for the Osteoporotic Fractures in Men (MrOS) Study Group (2014) Implications of expanding indications for drug treatment to prevent fracture in older men in United States: cross sectional and longitudinal analysis of prospective cohort study. BMJ 349:g4120CrossRefGoogle Scholar
  15. 15.
    Ferrari R (2015) Prevalence of osteoporosis in men aged 65-75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening. Clin Rheumatol 34:523–537CrossRefPubMedGoogle Scholar
  16. 16.
    Kanis JA, McCloskey EV, Johansson H, Oden A, Melton LJ III, Khaltaev N (2008) A reference standard for the description of osteoporosis. Bone 42:467–475CrossRefPubMedGoogle Scholar
  17. 17.
    National Osteoporosis Foundation. Clinician’s guide to prevention and treatment of osteoporosis. NOF, 2014. Available at http://nof.org/files/nof/public/content/file/2791/upload/919.pdf)
  18. 18.
    Kanis JA, Johnell O, Oden A, Jonsson B, De Laet C, Dawson A (2000) Risk of hip fracture according to the World Health Organization criteria for osteopenia and osteoporosis. Bone 27:585–590CrossRefPubMedGoogle Scholar
  19. 19.
    O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European vertebral osteoporosis study. J Bone Miner Res 11:1008–1010Google Scholar
  20. 20.
    McCloskey EV, Spector TD, Eyres KS, Fern ED, O’Rourke N, Vasikaran S, Kanis JA (1993) The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int 3:138–147CrossRefPubMedGoogle Scholar
  21. 21.
    Eastell R, Cedel SL, Wahner HW, Riggs BL, Melton LJ 3rd (1991) Classification of vertebral fractures. J Bone Miner Res 6:207–215CrossRefPubMedGoogle Scholar
  22. 22.
    Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMedGoogle Scholar
  23. 23.
    Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J (2010) Bone turnover markers in Spanish adult men. The Camargo Cohort Study. Clin Chim Acta 411:1511–1515CrossRefPubMedGoogle Scholar
  24. 24.
    Olmos JM, Hernández JL, García-Velasco P, Martínez J, Llorca J, González-Macías J (2016) Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults. Osteoporos Int 27:105–113CrossRefPubMedGoogle Scholar
  25. 25.
    Hernández JL, Olmos JM, Romaña G, Martínez J, Castillo J, Yezerska I, Pinedo G, González-Macías J (2014) Bone mineral density in statin users: a Spanish cohort. J Bone Miner Metab 32:184–191CrossRefPubMedGoogle Scholar
  26. 26.
    Miyasaka D, Endo N, Endo E, Sakuma M, Yamamoto N, Tanabe N, Imai N, Suda K (2016) Incidence of hip fracture in Niigata, Japan in 2004 and 2010 and the long-term trends from 1985 to 2010. J Bone Miner Metab 34:92–98CrossRefPubMedGoogle Scholar
  27. 27.
    Hernández JL, Olmos JM, Alonso MA, González-Fernández CR, Martínez J, Pajarón M, Llorca J, González-Macías J (2006) Trend in hip fracture epidemiology over a 14-year period in a Spanish population. Osteoporos Int 17:464–470CrossRefPubMedGoogle Scholar
  28. 28.
    Kanis JA on behalf of the World Health Organization Scientific Group (2008) Assessment of osteoporosis at the primary healthcare level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2007: University of Sheffield. http://www.shef.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf
  29. 29.
    Kanis JA, Oden A, McCloskey EV, Johansson H, Wahl DA, Cooper C, Working IOF, Group on Epidemiology and Quality of Life (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA, Fujiwara S, Kroger H, Mellstrom D, Meunier PJ, Melton LJ 3rd, O’Neill T, Pols H, Reeve J, Silman A, Tenenhouse A (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20:1185–1194CrossRefPubMedGoogle Scholar
  31. 31.
    Kanis JA, Bianchi G, Bilezikian JP, Kaufman JM, Khosla S, Orwoll E, Seeman E (2011) Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int 22:2789–2798CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Díaz López JB, Naves Díaz M, Gómez Alonso C, Fernández Martín JL, Rodríguez Rebollar A, Cannata Andía JB (2000) Prevalencia de fractura vertebral en población asturiana mayor de 50 años de acuerdo a diferentes criterios radiológicos. Med Clin (Barc) 115:326–331CrossRefGoogle Scholar
  33. 33.
    Ensrud KE, Blackwell TL, Fink HA, Zhang J, Cauley JA, Cawthon PM, Black DM, Bauer DC, Curtis JR, Orwoll ES, Barrett-Connor E, Kado DM, Marshall LM, Shikany JM, Schousboe JT; Osteoporotic Fractures in Men (MrOS) Research Group (2016) What proportion of incident radiographic vertebral fractures in older men is clinically diagnosed and vice versa: a prospective study. J Bone Miner Res 31:1500–1503CrossRefGoogle Scholar
  34. 34.
    Briot K, Fechtenbaum J, Roux C (2016) Clinical relevance of vertebral fractures in men. J Bone Miner Res 31:1497–1499CrossRefPubMedGoogle Scholar

Copyright information

© The Japanese Society for Bone and Mineral Research and Springer Japan 2017

Authors and Affiliations

  1. 1.Department of Internal MedicineHospital Universitario Marqués de Valdecilla-IDIVAL, Universidad de CantabriaSantanderSpain
  2. 2.Red Temática de Investigación Cooperativa en Envejecimiento y Fragilidad (RETICEF)Instituto de Salud Carlos IIISantanderSpain
  3. 3.Clinical Biochemistry ServiceHospital Universitario Marqués de Valdecilla-IDIVAL, Universidad de CantabriaSantanderSpain
  4. 4.Centro de Salud de CamargoUniversidad de CantabriaSantanderSpain
  5. 5.GREMPAL Research Group, Idiap Jordi Gol Primary Care Research Institute, Hospital del Mar-IMIMUniversitat Autònoma de Barcelona, RETICEF, Instituto de Salud Carlos IIIBarcelonaSpain
  6. 6.Oxford NIHR Musculoskeletal Biomedical Research Unit, Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal SciencesUniversity of OxfordOxfordUK

Personalised recommendations